Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China flag China · Delayed Price · Currency is CNY
3.690
-0.010 (-0.27%)
Sep 5, 2025, 10:45 AM CST

SHA:600664 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
9,29310,4018,4457,5998,9407,997
Upgrade
Market Cap Growth
39.24%23.17%11.14%-15.00%11.79%-15.83%
Upgrade
Enterprise Value
8,2919,8348,3738,60810,4448,672
Upgrade
Last Close Price
3.694.133.353.013.553.19
Upgrade
PE Ratio
17.5116.5421.3716.3424.09-
Upgrade
Forward PE
14.1914.9114.9114.9114.9114.91
Upgrade
PS Ratio
0.580.640.550.550.700.74
Upgrade
PB Ratio
1.461.711.561.542.022.01
Upgrade
P/TBV Ratio
1.802.122.001.982.692.68
Upgrade
P/FCF Ratio
19.9015.049.7814.27--
Upgrade
P/OCF Ratio
16.0913.138.8912.22--
Upgrade
EV/Sales Ratio
0.510.610.540.620.820.80
Upgrade
EV/EBITDA Ratio
8.359.239.5310.4814.57-
Upgrade
EV/EBIT Ratio
11.1411.5713.5415.4323.33-
Upgrade
EV/FCF Ratio
17.7514.229.7016.17--
Upgrade
Debt / Equity Ratio
0.210.290.340.440.520.45
Upgrade
Debt / EBITDA Ratio
1.321.582.012.483.06-
Upgrade
Debt / FCF Ratio
2.802.552.154.04--
Upgrade
Asset Turnover
1.141.131.121.051.040.89
Upgrade
Inventory Turnover
6.146.116.145.405.014.39
Upgrade
Quick Ratio
1.131.080.990.930.820.77
Upgrade
Current Ratio
1.441.361.261.201.111.07
Upgrade
Return on Equity (ROE)
9.76%12.00%9.15%10.94%9.75%-21.05%
Upgrade
Return on Assets (ROA)
3.29%3.70%2.81%2.65%2.27%-4.12%
Upgrade
Return on Capital (ROIC)
6.01%7.02%5.38%5.04%4.48%-8.11%
Upgrade
Return on Capital Employed (ROCE)
11.00%13.10%10.50%10.30%9.00%-
Upgrade
Earnings Yield
5.87%6.05%4.68%6.12%4.15%-13.48%
Upgrade
FCF Yield
5.03%6.65%10.22%7.01%-2.67%-10.58%
Upgrade
Payout Ratio
8.16%7.49%11.17%11.68%16.59%-
Upgrade
Buyback Yield / Dilution
-8.19%-1.82%4.40%-4.46%1.29%10.19%
Upgrade
Total Shareholder Return
--1.82%4.40%-4.46%1.29%10.19%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.